KM02894

Biorbyt

KM02894

10

116850-74-9

Research Use Only

98.72%

C7H9N3OS2

215.3

KM02894 is a glutamate release inhibitor. Cancer cells release high levels of glutamate that can disrupt normal bone turnover, which can lead to cancer-induced bone pain.KM02894 may be used in the study of tumor-related diseases.

CNC(=S)NNC(=O)C1=CC=CS1

-20°C

12352200